Back to Royal Bank of Canada Royal Bank of Canada

SAVASAVA

Showing 8 of 28 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in FILANA THERAPEUTICS INC

Yes. Royal Bank of Canada holds 314 shares of SAVA (Filana Therapeutics) as of its Q2 2026 13F filing. It reduced the position by 1,239 shares (-79.8%) from Q1 2026. Royal Bank of Canada has held SAVA since Q2 2020, across 25 quarterly 13F filings.

Current Value

$0

Current Shares

314

Total Value Change

-$239,000

Total Shares Change

-7,801

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
314
-79.8%
$00.0%$1.19
0
2026-Q1
Decreased
1,553
-71.8%
$3,0000.0%$1.69
0
2025-Q4
Decreased
5,498
-92.5%
$10,0000.0%$1.98
0
2025-Q3
Decreased
73,239
-13.7%
$213,0000.0%$2.91
0
2025-Q2
Increased
84,831
+7776.6%
$153,0000.0%$1.81
25
2025-Q1
Decreased
1,077
-73.1%
$1,0000.0%$1.50
0
2024-Q4
Decreased
4,008
-50.6%
$10,0000.0%$2.36
0
2024-Q3
Decreased
8,115
-4.4%
$239,0000.0%$29.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used